APOE Genotype: No Influence on Galantamine Treatment Efficacy Nor on Rate of Decline in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|12|2|69-77

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.12, Iss.2, 2001-02, pp. : 69-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

APOE Genotype and Alzheimer´s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 4, 2000-06 ,pp. : 237-237

Karger

Access to resources Recommend Favorite

Pattern and Progression of Cognitive Decline in Alzheimer’s Disease: Role of Premorbid Intelligence and ApoE Genotype

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 6, 2007-11 ,pp. : 483-491

Karger

Access to resources Recommend Favorite

Effect of the Apolipoprotein E ε4 Allele on the Efficacy and Tolerability of Galantamine in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 1, 2005-12 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Patterns of Cortical Thickness according to APOE Genotype in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 5, 2009-11 ,pp. : 461-470

Karger

Access to resources Recommend Favorite

Cognitive Impairment in Alzheimer’s Disease Is Modified by APOE Genotype

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 2, 2007-06 ,pp. : 98-103

Karger

Access to resources Recommend Favorite